Robbins LLP Encourages GOSS Stockholders Who Lost Money Investing in Gossamer Bio, Inc. to Contact the Firm for Information About Leading the Class Action

SAN DIEGO, April 15, 2026 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Gossamer Bio, Inc. (NASDAQ: GOSS) securities between June 16, 2025 and February 20, 2026. Gossamer is a clinical stage...